Prescription drug · NDA AUTHORIZED GENERIC
Fluticasone Furoate Ellipta (Fluticasone furoate) NDC 66993-166
Fluticasone furoate 50 ug/1 · Powder · Respiratory (Inhalation) · Prasco Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66993-166-97 | 6699301669766993016697 | 1 INHALER in 1 CARTON (66993-166-97) / 30 POWDER in 1 INHALERMarketed from Jul 21, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluticasone Furoate Ellipta
- Generic name (nonproprietary)
- fluticasone furoate
- Active ingredients
- Fluticasone furoate — 50 ug/1
- Dosage form
- Powder
- Route
- Respiratory (Inhalation)
- Labeler
- Prasco LaboratoriesNDC labeler code 66993
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 205625
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 66993-166_e8bbbfc7-2521-45f9-a0a7-fbea79cebc06SPL ID e8bbbfc7-2521-45f9-a0a7-fbea79cebc06SPL set ID d3e797fc-2636-49a0-b89e-5246b18ee440RxCUI 1547658, 1547671, 2045377UNII JS86977WNV
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N466993016697followed by a unit qualifier and the quantityPackage 66993-0166-97. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Fluticasone Furoate ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older. Limitations of Use Fluticasone Furoate ELLIPTA is NOT indicated for the relief of acute bronchospasm. Fluticasone Furoate ELLIPTA is an inhaled corticosteroid indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older. ( 1 ) Limitations of Use: Not indicated for relief of acute bronchospasm. ( 1 , 5.2 )
Excerpt only. Read the full label for complete information.
About NDC 66993-166
- What is NDC 66993-166?
- 66993-166 is the product NDC for Fluticasone Furoate Ellipta (fluticasone furoate), Fluticasone furoate 50 ug/1 powder, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Fluticasone Furoate Ellipta (Fluticasone furoate).
- What is the active ingredient?
- Fluticasone furoate.
- Who is the labeler?
- Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Fluticasone Furoate Ellipta?
- 2 other product NDCs are listed under this name. See all Fluticasone Furoate Ellipta NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Fluticasone Furoate Ellipta products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Fluticasone Furoate Elliptafluticasone furoate | Fluticasone furoate 100 ug/1 | PowderRespiratory (Inhalation) | Prasco Laboratories | 66993-167 | 66993-0167-97 |
| Fluticasone Furoate Elliptafluticasone furoate | Fluticasone furoate 200 ug/1 | PowderRespiratory (Inhalation) | Prasco Laboratories | 66993-168 | 66993-0168-97 |
Other NDCs under NDA 205625
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 100 ug/1 | PowderRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0874 |
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 200 ug/1 | PowderRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0876 |
| Arnuity Elliptafluticasone furoate | Fluticasone furoate 50 ug/1 | PowderRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0888 |
| Fluticasone Furoate Elliptafluticasone furoate | Fluticasone furoate 100 ug/1 | PowderRespiratory (Inhalation) | Prasco Laboratories | 66993-167 |
| Fluticasone Furoate Elliptafluticasone furoate | Fluticasone furoate 200 ug/1 | PowderRespiratory (Inhalation) | Prasco Laboratories | 66993-168 |